Idiopathic sudden deafness | Canada Hyperbarics Skip to main content
Review Rev Med Interne 2002

Idiopathic sudden deafness

Mom T, Avan P, Gilain L — Rev Med Interne, 2002

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

This review article explored the causes, diagnosis, and medical management of sudden idiopathic deafness, a type of sensorineural hearing loss with no clear cause.

What They Found

The researchers found that high-dose corticotherapy is the primary emergency treatment for sudden idiopathic deafness. They noted that other treatments have not been consistently proven effective. Frequent causes are likely reactivation of neurotropic viruses and/or cochlear ischaemia.

What This Means for Canadian Patients

For Canadian patients experiencing sudden idiopathic deafness, this review suggests that high-dose corticotherapy is the main recommended emergency treatment. It highlights the importance of quickly diagnosing the condition and ruling out other causes like tumours. Patients should discuss immediate treatment options with their healthcare provider.

Canadian Relevance

No direct Canadian connection identified. Sudden idiopathic deafness is not a Health Canada-recognised indication for hyperbaric oxygen therapy.

Study Limitations

A limitation is that this review was published in 2002, so newer research and treatment options may have emerged since then.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Review
Category Sudden Hearing Loss
Source Pubmed
PubMed ID 11928377
Year Published 2002
Journal Rev Med Interne
MeSH Terms Adrenal Cortex Hormones; Adult; Antiviral Agents; Child; Cochlea; Hearing Loss, Sudden; Hemodilution; Humans; Hyperbaric Oxygenation; Laser-Doppler Flowmetry; Magnetic Resonance Imaging; Neuroma, Acoustic; Prognosis; Retrocochlear Diseases; Tomography, Emission-Computed; Vasodilator Agents

Cite This Study

Share

This study relates to Sudden Sensorineural Hearing Loss. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Sudden Hearing Loss

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 17, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology